Capital Asset Advisory Services’s AbCellera Biologics ABCL Stock Holding History

Capital Asset Advisory Services’s Portfolio ABCL Stock Details ABCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-93	Closed	-$4K	–	690
2020 Q4	$4K	Buy	+93	New	+$4.25K	﹤0.01%	1300

Other funds holding ABCL

Viking Global Investors

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

SB Management Abu Dhabi, United Arab Emirates $512M AUM 40.71% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return

Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return

Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return